Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,3413,360 of 20,252 grants

Active NON-SBIR/STTR RPGS
Mechanism of double-negative T cells in antitumor immunity to breast cancer
NATIONAL CANCER INSTITUTE Washington State University United States 2023 – 2028

Abstract: Breast cancer (BC), the most common cancer globally as of 2021 and accounting for 12% of all new annual cancer cases worldwide, is the most commonly diagnosed cancer amon...

$3.35M
USD
Active NON-SBIR/STTR RPGS
Prevalence and persistence of the ETV6/RUNX1 pre-leukemic clone
NATIONAL CANCER INSTITUTE University of Minnesota United States 2023 – 2028

Abstract Leukemia is the most common childhood cancer and represents approximately one third of all cancer diagnoses among children age 0-14. There is strong evidence that acute ly...

$7.29M
USD
Completed OTHER RESEARCH-RELATED
Inter-organellar communication in metabolic reprogramming of colorectal cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2025

PROJECT SUMMARY Colorectal cancers (CRC) are characterized as having a hierarchical organization requiring proliferating and de-differentiated stem cells to maintain tumor growth a...

$420.9K
USD
Active NON-SBIR/STTR RPGS
Innovative Rapid Enabling, Affordable, point-of-Care HPV Self-Testing Strategy (I-REACH)
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2028

Abstract Each day, there are an estimated 28 cervical cancer deaths in Nigeria, making cervical cancer the second most common cancer among women in the entire country. Only a minor...

$4.67M
USD
Completed OTHER RESEARCH-RELATED
Real Time Metabolic Imaging to Interrogate Early Detection and Prevention of Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2025

Project Summary Pancreatic ductal adenocarcinoma (PDAC) has a median 5-year survival of only 11%, and early diagnosis of PDAC is recognized as one of the highest priority areas by...

$369.6K
USD
Active NON-SBIR/STTR RPGS
Targeting the Immunosuppressive Tumor Microenvironment for Colorectal Cancer Treatment
NATIONAL CANCER INSTITUTE University of Kentucky United States 2023 – 2028

Project Summary/Abstract Despite notable improvements in colorectal cancer (CRC) treatment, the prognosis of patients with metastatic CRC (mCRC) remains poor, with a median overall...

$4M
USD
Active TRAINING, INDIVIDUAL
Role of hypoxia in fibroblast reprogramming in pancreatic cancer
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2026

PROJECT SUMMARY Pancreatic ductal adenocarcinoma (PDAC) is a prevalent form of pancreatic cancer, accounting for about 90% of all cases of this disease. PDAC is highly fatal, where...

$408.1K
USD
Active TRAINING, INDIVIDUAL
Dissecting the role of GPR34 in cDC1 migration and function
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT As critical mediators of immunity against intracellular pathogens and cancer, type 1 conventional dendritic cells (cDC1s) cross-present exogenous, cell-ass...

$398K
USD
Active TRAINING, INDIVIDUAL
Molecular MR-PET to characterize malignant transformation and identify therapeutic vulnerabilities in human IDH-mutant gliomas
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT The World Health Organization (WHO) classification of gliomas has been steadily shifting from a histological classification towards a molecular classificat...

$400.8K
USD
Completed TRAINING, INDIVIDUAL
Tri-Signal Artificial Antigen Presenting Cells for Cancer Immunotherapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2026

PROJECT SUMMARY Adoptive cellular therapy (ACT) treatments, in which cancer patients are infused with autologous tumor- specific cytotoxic (CD8+) T cells expanded and activated ex...

$476.9K
USD
Active NON-SBIR/STTR RPGS
Roles of LMP1 and MYC in EBV-induced B-cell tumors
NATIONAL CANCER INSTITUTE University of Wisconsin-Madison United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Epstein-Barr virus (EBV) is an important cause of human lymphomas in both immunocompetent and immunosuppressed humans, including Burkitt lymphomas (BLs), H...

$4.51M
USD
Active TRAINING, INDIVIDUAL
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Sacrococcygeal teratomas (SCTs) are the most common tumor in newborns, have significant perinatal morbidity and mortality, a 35% rate of recurrence, and la...

$398K
USD
Active TRAINING, INDIVIDUAL
Alternate splicing as a source of shared neoantigens in a non-small cell lung cancer
NATIONAL CANCER INSTITUTE University of Connecticut Sch of Med/Dnt United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality in the United States. Immune checkpoint inhibitors (ICIs) like anti-PD-1 have i...

$526.9K
USD
Active TRAINING, INDIVIDUAL
Mechanisms of pathogenic gene activation by aberrant transcriptional hubs formed by mutant ENL
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2023 – 2026

PROJECT SUMMARY Transcription is an essential and tightly regulated process that requires the coordination of many factors to ensure proper gene expression. Current models of trans...

$476.9K
USD
Active TRAINING, INDIVIDUAL
Understanding the role of β2AR-signaling on ILC2 differentiation/plasticity and its implications in cancer progression
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2023 – 2027

Project Summary / Abstract: In preclinical models, norepinephrine released by sympathetic nerves during chronic stress have been demonstrated to promote an immunosuppressive tumor...

$325.1K
USD
Active TRAINING, INDIVIDUAL
Determining the role of nuclear envelope reformation proteins in regulating the cGAS/STING innate immune response in cancer
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT: In cancer cells, exposure of self DNA to the cytosol is driven by a variety of genomic instabilities such as micronuclei, chromatin bridges, and nuclear r...

$476.9K
USD
Active TRAINING, INDIVIDUAL
SEMIColon: Somatic Exploration of Mosaicism in Colon
NATIONAL CANCER INSTITUTE University of Utah United States 2023 – 2027

Project Summary/Abstract If we understand the somatic mosaicism of healthy tissues and how this changes through pathogenesis, we will be better equipped to screen for, monitor, and...

$489.7K
USD
Active NON-SBIR/STTR RPGS
Identification of DCLK2-TBK1 signaling axis as a potential therapeutic target in kidney cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

Project Summary Clear cell renal cell carcinoma (ccRCC), which accounts for approximately 85% of all renal cancers, is resistant to a variety of cancer therapies and is highly leth...

$4.86M
USD
Completed TRAINING, INDIVIDUAL
ATF4-SCD axis in bone metastatic prostate cancer
NATIONAL CANCER INSTITUTE Wayne State University United States 2023 – 2025

Project Summary Bone metastatic disease correlates with increased morbidity and mortality in prostate cancer (PCa) patients. Various studies, including our own, have determined tha...

$452.5K
USD
Completed OTHER RESEARCH-RELATED
Support for the 2023 Society of Basic Urological Diseases annual meeting
NATIONAL CANCER INSTITUTE University of Washington United States 2023 – 2024

PROJECT SUMMARY: This application requests support for 30 Trainee Travel Awards for the Society for Basic Urologic Research (SBUR) 2023 Fall Meeting entitled, “Advances in Basic Ur...

$150K
USD